Literature DB >> 10455907

Cyclooxygenase-2 alters transforming growth factor-beta 1 response during intestinal tumorigenesis.

C A O'Mahony1, R D Beauchamp, D Albo, M Tsujii, H M Sheng, J Shao, R N Dubois, D H Berger.   

Abstract

BACKGROUND: Recent investigation suggests that cyclooxygenase-2 plays an important role in colorectal carcinogenesis. Transforming growth factor-beta1 (TGF-beta 1) is one of the most potent stimulators of cyclooxygenase-2 expression. A key step in intestinal tumorigenesis involves alteration of the normal cellular response to TGF-beta 1. We have hypothesized that overexpression of cyclooxygenase-2 alters intestinal epithelial response to TGF-beta 1.
METHODS: RIE-1 cells were stably transfected with rat cyclooxygenase-2 complementary DNA in either the sense (RIE-S) or antisense (RIE-AS) orientation. Tumor cell invasion was assessed with a modified Boyden collagen type I invasion assay in the presence of TGF-beta 1, antibody to urokinase plasminogen activator (uPA), or the selective cyclooxygenase-2 inhibitor SC-58125. Expression of uPA, uPA receptor, and plasminogen activator inhibitor-1 were determined by Western blot and enzyme-linked immunosorbent assay.
RESULTS: RIE-1 and RIE-AS did not invade although RIE-S cells were minimally invasive at baseline. TGF-beta 1 had no effect on RIE-1 or RIE-AS invasion; however, TGF-beta 1 significantly upregulated RIE-S cell invasion. All 3 RIE cell lines produce minimal uPA under basal conditions. TGF-beta 1 upregulated uPA production only in the RIE-S cells. Both antibody to uPA and SC-58125 reversed TGF-beta-mediated RIE-S cell invasion. SC-58125 inhibited TGF-beta-mediated RIE-S uPA production.
CONCLUSIONS: These results demonstrate that overexpression of cyclooxygenase-2 alters intestinal epithelial response to TGF-beta 1, which may be a mechanism by which cyclooxygenase-2 promotes colon carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10455907

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  9 in total

1.  Prediagnostic non-steroidal anti-inflammatory drug use and survival after diagnosis of colorectal cancer.

Authors:  Anna E Coghill; Polly A Newcomb; Peter T Campbell; Andrea N Burnett-Hartman; Scott V Adams; Elizabeth M Poole; John D Potter; Cornelia M Ulrich
Journal:  Gut       Date:  2010-11-04       Impact factor: 23.059

2.  Paclitaxel combined with harmine inhibits the migration and invasion of gastric cancer cells through downregulation of cyclooxygenase-2 expression.

Authors:  Kun Sun; Xiao-He Tang; Yi-Kui Xie
Journal:  Oncol Lett       Date:  2015-06-25       Impact factor: 2.967

3.  The correlation between tumor-infiltrating Foxp3+ regulatory T cells and cyclooxygenase-2 expression and their association with recurrence in resected head and neck cancers.

Authors:  Dian-Shui Sun; Miao-Qing Zhao; Ming Xia; Li Li; Yu-Hua Jiang
Journal:  Med Oncol       Date:  2011-03-22       Impact factor: 3.064

4.  Protein-bound polysaccharide PSK inhibits tumor invasiveness by down-regulation of TGF-beta1 and MMPs.

Authors:  H Zhang; T Morisaki; H Matsunaga; N Sato; A Uchiyama; K Hashizume; F Nagumo; J Tadano; M Katano
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

5.  Expression of cyclooxygenase-2 and clinicopathologic features in human gastric adenocarcinoma.

Authors:  Ying-Wei Xue; Qi-Fan Zhang; Zhi-Bing Zhu; Qi Wang; Song-Bin Fu
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

6.  Role of cyclooxygenase-2 in tumor progression and survival of head and neck squamous cell carcinoma.

Authors:  Nabil F Saba; Misun Choi; Susan Muller; Hyung Ju C Shin; Mourad Tighiouart; Vassiliki A Papadimitrakopoulou; Adel K El-Naggar; Fadlo R Khuri; Zhuo Georgia Chen; Dong M Shin
Journal:  Cancer Prev Res (Phila)       Date:  2009-09-08

7.  Hierarchical investigating the predictive value of p53, COX2, EGFR, nm23 in the post-operative patients with colorectal carcinoma.

Authors:  Peng Du; Bin Xu; Dachuan Zhang; Yingjie Shao; Xiao Zheng; Xiaodong Li; Yuqi Xiong; Changping Wu; Jingting Jiang
Journal:  Oncotarget       Date:  2017-01-03

Review 8.  Medical Application of Spirulina platensis Derived C-Phycocyanin.

Authors:  Qian Liu; Yinghong Huang; Ronghua Zhang; Tiange Cai; Yu Cai
Journal:  Evid Based Complement Alternat Med       Date:  2016-05-11       Impact factor: 2.629

Review 9.  Cyclooxygenase 2-Regulated Genes an Alternative Avenue to the Development of New Therapeutic Drugs for Colorectal Cancer.

Authors:  Alicia M Hidalgo-Estévez; Konstantinos Stamatakis; Marta Jiménez-Martínez; Ricardo López-Pérez; Manuel Fresno
Journal:  Front Pharmacol       Date:  2020-04-29       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.